125 related articles for article (PubMed ID: 2621574)
1. 6-bis-(2-chloroethyl)amino-6-deoxy-D-galactopyranose hydrochloride: synthesis, chemical characterization, murine P388 antitumor activity, and bone marrow toxicity.
Schein PS; Green D; Hammer CF; McPherson E; Talebian A
J Pharm Sci; 1989 Nov; 78(11):918-21. PubMed ID: 2621574
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
3. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
4. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
5. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
6. A new steroidal alkylating agent with improved activity in advanced murine leukemias.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1979; 3(1):67-70. PubMed ID: 535128
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
Roehrig GR; Billman JH; Marcec J; Fritz P; Shea F
J Pharm Sci; 1980 Oct; 69(10):1232-4. PubMed ID: 7420301
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
9. Activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxyacetate (NSC 294859) on experimental animal tumor and leukemia systems.
Catsoulacos P
Oncology; 1983; 40(4):290-2. PubMed ID: 6866424
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Avramis VI; Plunkett W
Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumour effect of alpha-amino N-substituted-pyrrolidin-2,5-dione-N-mustards on the growth of P388 lymphocytic leukaemia.
Naik SD; Ambaye RY; Gokhale SV
J Cancer Res Clin Oncol; 1987; 113(2):151-4. PubMed ID: 3455198
[TBL] [Abstract][Full Text] [Related]
12. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
Catsoulacos P; Camoutsis C; Wampler GL
Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
[TBL] [Abstract][Full Text] [Related]
13. Modulation by taurine of the toxicity of taumustine, a compound with antitumor activity.
Pierson HF; Fisher JM; Rabinovitz M
J Natl Cancer Inst; 1985 Nov; 75(5):905-9. PubMed ID: 3863989
[TBL] [Abstract][Full Text] [Related]
14. In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.
Lazarus P; Dufour M; Isabel G; Panasci LC
Cancer Chemother Pharmacol; 1986; 16(2):148-52. PubMed ID: 3948300
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
16. bis-Mannich bases of styryl ketones as antileukemic agents.
Dimmock JR; Shyam K; Hamon NW; Patil SA; Smith PJ
Neoplasma; 1985; 32(1):85-91. PubMed ID: 3982563
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
18. Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluation.
Papaconstantinou IC; Fousteris MA; Koutsourea AI; Pairas GN; Papageorgiou AD; Nikolaropoulos SS
Anticancer Drugs; 2013 Jan; 24(1):52-65. PubMed ID: 23187313
[TBL] [Abstract][Full Text] [Related]
19. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid and [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1983; 10(2):129-32. PubMed ID: 6831626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
